Related Experiment Video
Updated: Jul 13, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
CD45 expression in low-grade B-cell non-Hodgkin's lymphomas
Giovanni Carulli1, Elisa Cannizzo, Alessandra Zucca
1Division of Hematology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Italy. g.carulli@ao-pista.toscana.it
CD45 glycoprotein levels vary across low-grade non-Hodgkin's lymphomas (NHL). This study characterizes CD45 expression patterns in various NHL subtypes, revealing distinct maturation levels and aiding in neoplasia characterization.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- CD45 is a glycoprotein crucial for lymphohemopoietic cell function, with expression levels changing during B-lymphocyte development.
- Limited data exist on CD45 expression in diverse low-grade B-cell non-Hodgkin's lymphomas (NHL), with prior reports suggesting variable levels in chronic lymphocytic leukemia (CLL) and other NHLs.
Purpose of the Study:
- To investigate and delineate CD45 expression patterns across various subtypes of low-grade B-cell non-Hodgkin's lymphomas (NHL).
- To assess if CD45 expression can serve as a marker for B-lymphocyte maturation and aid in characterizing NHL subtypes.
Main Methods:
- Flow cytometry was used to evaluate CD45 expression in bone marrow samples from 107 NHL patients, including typical CLL, atypical CLL, mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), follicular lymphoma (FL), and hairy cell leukemia (HCL).
- Pathologic B-lymphocytes were identified using specific immunophenotypic markers (CD19/kappa or CD19/lambda).
- A CD45 index was calculated by normalizing the median fluorescence intensity (MFI) of pathologic B-lymphocytes to that of autologous T-lymphocytes to account for inter-sample variability.
Main Results:
- Four distinct CD45 expression patterns were identified: very low in typical CLL, relatively low in MCL, intermediate in MZL, LPL, and FL, and very high in HCL.
- Atypical cases, including one CD23-negative CLL, one CD23-positive MCL, and CLL with atypical morphology, exhibited very high CD45 expression.
- CD45 expression levels correlated with B-lymphocyte maturation stages across the studied NHL subtypes.
Conclusions:
- CD45 expression patterns differ significantly among low-grade NHL subtypes, reflecting varying B-lymphocyte maturation levels.
- The CD45 index provides a valuable tool for characterizing NHLs and may assist in distinguishing between subtypes and assessing disease characteristics.
- These findings contribute to a better understanding of B-cell lymphomagenesis and offer potential for improved diagnostic and prognostic stratification.
More Related Videos
07:17Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018